Clearside Biomedical Inc
NASDAQ:CLSD
Income Statement
Earnings Waterfall
Clearside Biomedical Inc
Revenue
|
8.2m
USD
|
Cost of Revenue
|
-355k
USD
|
Gross Profit
|
7.9m
USD
|
Operating Expenses
|
-32.7m
USD
|
Operating Income
|
-24.8m
USD
|
Other Expenses
|
-7.6m
USD
|
Net Income
|
-32.5m
USD
|
Income Statement
Clearside Biomedical Inc
Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
1
N/A
|
1
+2%
|
1
+2%
|
1
-2%
|
0
-92%
|
0
+300%
|
0
+94%
|
0
+13%
|
0
N/A
|
0
-37%
|
0
-73%
|
0
-50%
|
0
+167%
|
0
+63%
|
0
+108%
|
2
+704%
|
6
+187%
|
7
+5%
|
10
+50%
|
8
-20%
|
4
-52%
|
4
+11%
|
4
-8%
|
30
+660%
|
30
+1%
|
29
-1%
|
27
-9%
|
1
-95%
|
1
-26%
|
2
+65%
|
2
+36%
|
8
+272%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
0
N/A
|
1
N/A
|
2
+77%
|
8
+374%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||
Operating Expenses |
(15)
|
(17)
|
(19)
|
(19)
|
(21)
|
(26)
|
(30)
|
(39)
|
(52)
|
(59)
|
(65)
|
(72)
|
(78)
|
(83)
|
(82)
|
(67)
|
(49)
|
(32)
|
(24)
|
(24)
|
(24)
|
(26)
|
(27)
|
(28)
|
(30)
|
(30)
|
(30)
|
(31)
|
(30)
|
(31)
|
(31)
|
(31)
|
(32)
|
(33)
|
|
Selling, General & Administrative |
(6)
|
(7)
|
(7)
|
(5)
|
(5)
|
(6)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(13)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(16)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(11)
|
(12)
|
(12)
|
(12)
|
|
Research & Development |
(9)
|
(11)
|
(13)
|
(15)
|
(16)
|
(19)
|
(22)
|
(30)
|
(42)
|
(49)
|
(55)
|
(61)
|
(65)
|
(68)
|
(66)
|
(49)
|
(32)
|
(16)
|
(9)
|
(11)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(18)
|
(19)
|
(18)
|
(20)
|
(20)
|
(19)
|
(20)
|
(21)
|
|
Operating Income |
(15)
N/A
|
(17)
-16%
|
(19)
-9%
|
(19)
0%
|
(21)
-10%
|
(25)
-21%
|
(30)
-19%
|
(39)
-28%
|
(51)
-33%
|
(58)
-14%
|
(65)
-11%
|
(72)
-11%
|
(78)
-8%
|
(83)
-7%
|
(82)
+1%
|
(67)
+19%
|
(49)
+26%
|
(30)
+38%
|
(18)
+41%
|
(18)
+0%
|
(14)
+22%
|
(18)
-30%
|
(23)
-31%
|
(24)
-2%
|
(26)
-10%
|
(1)
+98%
|
0
N/A
|
(2)
N/A
|
(3)
-111%
|
(30)
-770%
|
(30)
+0%
|
(30)
+2%
|
(30)
-1%
|
(25)
+17%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
|
Total Other Income |
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(6)
|
(8)
|
(9)
|
(9)
|
|
Pre-Tax Income |
(15)
N/A
|
(18)
-17%
|
(19)
-10%
|
(19)
+1%
|
(21)
-11%
|
(26)
-21%
|
(31)
-19%
|
(39)
-28%
|
(52)
-32%
|
(59)
-13%
|
(65)
-11%
|
(72)
-11%
|
(78)
-8%
|
(83)
-7%
|
(82)
+1%
|
(67)
+18%
|
(49)
+26%
|
(31)
+38%
|
(18)
+41%
|
(18)
0%
|
(14)
+22%
|
(18)
-28%
|
(23)
-24%
|
(23)
-2%
|
(25)
-11%
|
0
N/A
|
0
-79%
|
(2)
N/A
|
(5)
-180%
|
(33)
-621%
|
(35)
-5%
|
(36)
-4%
|
(37)
-4%
|
(32)
+13%
|
|
Net Income | |||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(15)
|
(18)
|
(19)
|
(19)
|
(21)
|
(26)
|
(31)
|
(39)
|
(52)
|
(59)
|
(65)
|
(72)
|
(78)
|
(83)
|
(82)
|
(67)
|
(49)
|
(31)
|
(18)
|
(18)
|
(14)
|
(18)
|
(23)
|
(23)
|
(25)
|
0
|
0
|
(2)
|
(5)
|
(33)
|
(35)
|
(36)
|
(37)
|
(32)
|
|
Net Income (Common) |
(15)
N/A
|
(18)
-17%
|
(19)
-10%
|
(19)
+1%
|
(21)
-11%
|
(26)
-21%
|
(31)
-19%
|
(39)
-28%
|
(52)
-32%
|
(59)
-13%
|
(65)
-11%
|
(72)
-11%
|
(78)
-8%
|
(83)
-7%
|
(82)
+1%
|
(67)
+18%
|
(49)
+26%
|
(31)
+38%
|
(18)
+41%
|
(18)
0%
|
(14)
+22%
|
(18)
-28%
|
(23)
-24%
|
(23)
-2%
|
(25)
-11%
|
0
N/A
|
0
-79%
|
(2)
N/A
|
(5)
-180%
|
(33)
-621%
|
(35)
-5%
|
(36)
-4%
|
(37)
-4%
|
(32)
+13%
|
|
EPS (Diluted) |
-0.78
N/A
|
-0.9
-15%
|
-0.99
-10%
|
-0.93
+6%
|
-1.03
-11%
|
-1.02
+1%
|
-1.22
-20%
|
-1.55
-27%
|
-2.05
-32%
|
-2.33
-14%
|
-2.43
-4%
|
-2.25
+7%
|
-2.42
-8%
|
-2.69
-11%
|
-2.39
+11%
|
-1.77
+26%
|
-1.28
+28%
|
-0.81
+37%
|
-0.4
+51%
|
-0.4
N/A
|
-0.32
+20%
|
-0.39
-22%
|
-0.39
N/A
|
-0.39
N/A
|
-0.42
-8%
|
0.01
N/A
|
0
N/A
|
-0.02
N/A
|
-0.07
-250%
|
-0.55
-686%
|
-0.57
-4%
|
-0.59
-4%
|
-0.61
-3%
|
-0.53
+13%
|